Crispr

The New York research team was able to send the Cas9 enzyme to locate and destroy a target within a particular strain of a harmful bacteria by engineering the CRISPR spacer sequences so that it matched the “bad microbe’s” genes.

Crispr is a guide molecule made of RNA, that allows a specific site of interest on the DNA double helix to be targeted.

For the first time, doctors in the U.S. have used the powerful gene-editing technique CRISPR to try to treat a patient with a genetic disorder.

In this planned trial, doctors will remove cancer patients' T cells, “CRISPR” them, and then reinfuse them in the hope that they will recognize and attack the patients' cancers.

Having CRISPRed the cells we next wanted to identify the types of modification that have been generated.

Two successful applications of the CRISPR-Cas9 system in an SCN- and cell-type-specific fashion [5] will all but certainly add to the common refrain of 'just CRISPR it' (grad students and postdocs, insert groan here).